Company intelligence / Profile preview

Tecnimede

Sintra, Lisboa, Portugaltecnimede.com ↗
Ownership
Private
Employees
~700
Development stage
Commercial
01

Overview

Tecnimede has a broad commercial portfolio of over +130 products marketed in more than100 countries. The company develops both generic medicines and innovative fixed-dose combinations/new chemical entities. Its R&D activities include preclinical studies through Phase II/III clinical trials for select programs. It has a strong focus on cardiovascular/metabolic/CNS/infectious disease areas.[1][2][5][6]

Therapeutic areas
Metabolic Disorders
Modalities
Small molecules (generics and new chemical entities)[8]Fixed-dose combinations[8]Modified release formulations[8]Sterile forms[8]
Industry
Pharma
02

Drug pipeline

2 assets

mono-magnesium L-aspartate hydrochloride

Unknown

1 more asset in the full pipeline.

Request access →
03

Partnerships

Academic collaborations with University of Coimbra and other European pharmacy faculties for research & contract development.[8]

Beyond the preview

Go deeper on Tecnimede.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tecnimede.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call